e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 9

Biomarkers for advancing diagnosis and prognosis in stroke

Steffen Tiedt; Alejandro Bustamante; Alan Cameron; Pol Camps-Renom; Gerrit M Grosse; Johanna Ospel; Bastian Volbers; Heinrich J. Audebert · 2026 · The Lancet Neurology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

The complexity and incomplete understanding of the pathophysiology of stroke poses substantial challenges to personalised medicine and the development of novel therapies, as reflected in the neutral results of many randomised trials. Current clinical algorithms lack the precision to diagnose stroke before hospital admission, predict disease progression and recovery, or assess recurrence risk. Biomarkers are urgently needed, yet the absence of a robust evidence base hinders their clinical translation. To lay the groundwork for addressing this knowledge gap, an international multidisciplinary pa

Abstract by Steffen Tiedt; Alejandro Bustamante; Alan Cameron; Pol Camps-Renom; Gerrit M Grosse; Johanna Ospel; Bastian Volbers; Heinrich J. Audebert, The Lancet Neurology (2026) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1016/s1474-4422(25)00480-6